The question patients ask most often — "Is the compounded version the same as the brand-name?" — deserves a more honest answer than either side of the debate typically provides. Brand manufacturers say no. Compounding pharmacies say essentially yes. The truth requires understanding what "equivalent" means in pharmacology and what it doesn't.

What "Compounded" Actually Means

Compounded semaglutide is prepared by pharmacies that source the raw active pharmaceutical ingredient (API) — semaglutide base or semaglutide sodium salt — and formulate it into an injectable solution. This is legal under two regulatory pathways: Section 503A (patient-specific prescriptions, state-regulated pharmacies) and Section 503B (outsourcing facilities, FDA-registered, subject to cGMP requirements).

Brand-name Wegovy and Ozempic are manufactured by Novo Nordisk under FDA-approved New Drug Applications (NDAs). They've undergone Phase I–III clinical trials demonstrating safety, efficacy, and consistent bioavailability. The finished product is FDA-approved.

Compounded versions use the same active molecule but have not been through the FDA approval process as finished products. They are not FDA-approved, not interchangeable with the brand in a regulatory sense, and not subject to the same batch-level testing and bioequivalence requirements as approved drugs.

The Equivalence Spectrum

Chemically: The active pharmaceutical ingredient is the same molecule — semaglutide. At the molecular level, there is no distinction between the API used by a compounding pharmacy and the API in Novo Nordisk's manufacturing. However, the semaglutide sodium salt form used by some compounders differs from Novo Nordisk's semaglutide base, and the FDA has flagged concerns about whether these produce identical pharmacokinetics.

Formulation: Brand-name products have proprietary formulations (excipients, pH buffers, stabilizers) that have been optimized through development. Compounded formulations may differ in these components, potentially affecting stability, shelf life, and injection-site tolerability.

Testing: Every batch of Wegovy/Ozempic is tested to FDA standards for potency, purity, sterility, and endotoxin levels. 503B outsourcing facilities are subject to FDA inspection and cGMP requirements but operate under less rigorous batch-release testing. 503A pharmacies are state-regulated, with requirements varying dramatically by jurisdiction.

Our Position

Compounded semaglutide from a reputable 503B outsourcing facility is a legitimate, legal medication option — but calling it "the same" as Wegovy is an oversimplification. The active molecule is identical. The finished product is not. Patients deserve to know this distinction so they can make an informed choice, not be told it's identical when it isn't, or told it's dangerous when the evidence doesn't support that either.

What Should Drive Your Decision

If your insurance covers brand-name Wegovy or Zepbound at an affordable copay, brand-name is the lower-risk option — period. Full FDA approval, consistent manufacturing, established bioavailability data.

If insurance doesn't cover brand-name and you'd be paying $800–$1,500/month out of pocket, compounded medication from a LegitScript-certified, 503B-sourced provider is a reasonable alternative that many clinicians support — at a fraction of the cost.

The worst option is choosing based on cost alone without verifying the pharmacy sourcing. Not all compounders are created equal. We verify pharmacy sourcing for every provider we list.

⚠️ Red Flags in Compounding

Be cautious of providers that won't disclose their pharmacy source, those using 503A pharmacies for what appears to be bulk production (a regulatory gray area), and any provider offering semaglutide at prices below $75/month — sourcing legitimate API at that price point is difficult, and dramatically low prices may indicate quality compromises.

📊 Pricing verified July 2026. We earn commissions from some providers below. This never influences rankings. We show dose-level pricing, pharmacy sourcing, and terms that other sites hide. Our methodology →
Found Health
🏥 Structured Program

Brand-name + compounded GLP-1 with coaching and insurance coordination. Over 250K patients.

$189/mo medication + $99 membership
See Real Pricing →
Paid link
GobyMeds
🔥 Lowest Verified

Sema $99/mo, tirz $133/mo. Free consult, free shipping, no membership. Code x7X72r saves $25.

$99/mo sema · $133/mo tirz
See Real Pricing →
Paid link · Compounded medications are not FDA-approved

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. All medications require evaluation by a licensed healthcare provider. Compounded medications are not FDA-approved. Individual results vary.